[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339977-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339977-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tissue-inhibitor-of-metalloproteinase-3-expression-affects-clinicopathological-features-and-prognosis-of-aflatoxin-b1-related-hepatocellular-carcinoma-original-article-observational-study","Tissue inhibitor of metalloproteinase-3 expression affects clinicopathological features and prognosis of aflatoxin B1-related hepatocellular carcinoma - ORIGINAL ARTICLE - Observational Study","","Dysregulated tissue inhibitor of metalloproteinase-3 (TIMP3) is linked to hepatocellular carcinoma progression, yet its relationship to clinicopathological features and prognosis in aflatoxin B1 (AFB1)-related hepatocellular carcinoma (AHCC) is unclear. A retrospective cohort of 182 AHCC patients was analyzed for TIMP3 expression in tumor tissues using immunohistochemistry. Associations with clinicopathological characteristics and survival outcomes were assessed by Kaplan-Meier and Cox regression, including risk and survival metrics.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tissue-inhibitor-of-metalloproteinase-3-expression-affects-clinicopathological-features-and-prognosis-of-aflatoxin-b1-related-hepatocellular-carcinoma-original-article-observational-study/339977/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tissue-inhibitor-of-metalloproteinase-3-expression-affects-clinicopathological-features-and-prognosis-of-aflatoxin-b1-related-hepatocellular-carcinoma-original-article-observational-study/339977.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study aim regarding TIMP3 in AHCC?","Question",{"text":63,"@type":64},"The study assesses how TIMP3 expression affects clinicopathological features and prognosis of aflatoxin B1-related hepatocellular carcinoma (AHCC).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was TIMP3 expression measured?",{"text":68,"@type":64},"TIMP3 expression in cancerous tissues was detected by immunohistochemistry.",{"name":70,"@type":61,"acceptedAnswer":71},"What outcomes were associated with low TIMP3 expression?",{"text":72,"@type":64},"Low TIMP3 expression significantly reduced median overall survival and median tumor recurrence-free survival, and it increased risk of death and tumor recurrence in Cox regression analysis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339977,1791089845,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","| W | J | H | World Journal of\u003Cbr>Hepatology |\n| --- | --- | --- | --- |\n\nSubmit a Manuscript: [https://www.f6publishing.com](https://www.f6publishing.com) World J Hepatol 2024 August 27; 16(8): 1131-1144  \nDOI: 10.4254/wjh.v16.i8.1131 ISSN 1948-5182 (online)  \nORIGINAL ARTICLE  \nObservational Study  \nTissue inhibitor of metalloproteinase-3 expression affects clinicopathological features and prognosis of aflatoxin B1-related hepatocellular carcinoma  \nQiu-Ju Liang, Qin-Qin Long, Feng-Qin Tian, Qun-Ying Su, Xiao-Ying Zhu, Xi-Dai Long  \nSpecialty type: Gastroenterology and hepatology  \nProvenance and peer review:  \nUnsolicited article; Externally peer reviewed.  \nPeer-review model: Single blind  \nPeer-review report’s classification Scientific Quality: Grade C, Grade D, Grade D  \nNovelty: Grade B, Grade C, Grade C  \nCreativity or Innovation: Grade B, Grade C, Grade C  \nScientific Significance: Grade B, Grade C, Grade C  \nP-Reviewer: Hashimoto N; Ueda H  \nReceived: March 6, 2024  \nRevised: June 27, 2024  \nAccepted: July 10, 2024  \nPublished online: August 27, 2024  \nProcessing time: 168 Days and 20.7 Hours  \nQiu-Ju Liang, Qin-Qin Long, Feng-Qin Tian, Qun-Ying Su, Xiao-Ying Zhu, Xi-Dai Long,  \nClinicopathological Diagnosis and Research Center, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise 533000, Guangxi Zhuang Autonomous Region, China  \nQiu-Ju Liang, Xi-Dai Long, Department of Tumor Pathology, Key Laboratory of Tumor Molecular Pathology of Guangxi Higher Education Institutes, Baise 533000, Guangxi Zhuang Autonomous Region, China  \nCo-first authors: Qiu-Ju Liang and Qin-Qin Long.  \nCorresponding author: Xi-Dai Long, MD, PhD, Professor, Research Scientist, Clinicopathological Diagnosis and Research Center, The Affiliated Hospital of Youjiang Medical University for Nationalities, No. 18 Zhongshan Road, Baise 533000, Guangxi Zhuang Autonomous Region, [China.](China. sjtulongxd@ymun.edu.cn)[ sjtulongxd@ymun.edu.cn](China. sjtulongxd@ymun.edu.cn)  \nAbstract  \nBACKGROUND  \nThe dysregulation of tissue inhibitor of metalloproteinase-3 (TIMP3) was positively correlated with the progression of hepatocellular carcinoma (HCC) . However, it is not clear whether TIMP3 expression is associated with the clinicopathological features and prognosis of aflatoxin B1 (AFB1)-related HCC (AHCC) .  \nAIM  \nTo assess the effects of TIMP3 expression on the clinicopathological features and prognosis of AHCC.  \nMETHODS  \nA retrospective study, including 182 patients with AHCC, was conducted to explore the link between TIMP3 expression in cancerous tissues and the clinicopathological characteristics and prognosis of AHCC. TIMP3 expression was detected by immunohistochemistry and its effects on the clinicopathological features and prognosis of AHCC were evaluated by Kaplan-Meier survival analysis and Cox regression survival analysis. Odds ratio, hazard ratio (HR), median overall survival time (MST), median tumor recurrence-free survival time (MRT), and corresponding 95% confidential interval (CI) was calculated to  \n WJH  [https://www.wjgnet.com](https://www.wjgnet.com) 1131 August 27, 2024  Volume 16  Issue 8   \nLiang QJ et al. TIMP3 and AHCC clinicopathological features and prognosis  \nevaluate the potential of TIMP3 expression in predicting AHCC prognosis.  \nRESULTS  \nKaplan-Meier survival analysis showed that compared with high TIMP3 expression, low TIMP3 expression in tumor tissues significantly decreased the MST (36.00 mo vs 18.00 mo) and MRT (32.00 mo vs 16 mo) of patients with AHCC. Multivariate Cox regression survival analysis further proved that decreased expression of TIMP3 increased the risk of death (HR = 2.85, 95%CI: 2.04-4.00) and tumor recurrence (HR = 2.26, 95%CI: 1.57-3.26) . Furthermore, decreased expression of TIMP3 protein in tissues with AHCC was significantly correlated with tumor clinicopathological features, such as tumor size, tumor grade and stage, tumor microvessel density, and tumor blood invasion. Ad","cbCaibG9Q6OzSsIO","https://ap.wps.com/l/cbCaibG9Q6OzSsIO","pdf",824935,15,"English","# Abstract\n## Background\n## Aim\n## Methods\n## Results\n## Conclusion\n# Citation and Identifiers","[{\"question\":\"What is the study aim regarding TIMP3 in AHCC?\",\"answer\":\"The study assesses how TIMP3 expression affects clinicopathological features and prognosis of aflatoxin B1-related hepatocellular carcinoma (AHCC).\"},{\"question\":\"How was TIMP3 expression measured?\",\"answer\":\"TIMP3 expression in cancerous tissues was detected by immunohistochemistry.\"},{\"question\":\"What outcomes were associated with low TIMP3 expression?\",\"answer\":\"Low TIMP3 expression significantly reduced median overall survival and median tumor recurrence-free survival, and it increased risk of death and tumor recurrence in Cox regression analysis.\"}]","Tissue inhibitor of metalloproteinase-3 expression affects clinicopathological features and prognosis of aflatoxin B1-related hepatocellular carcinoma - ORIGINAL ARTICLE - Observational Study | PDF",1790033455,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bbf2ac79129d7ac08d5b4d017830c375.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71ad25b0622eb31b3ec53d0e250fb694.webp",982,1389,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/00dc4b55c0e5e184a462a622b8664a0a.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b37e91273fdc6da700191ce465af014b.webp",980,1386]